Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript

Editas Medicine, Inc. misses on earnings expectations. Reported EPS is $-0.76 EPS, expectations were $-0.63. Editas Medicine, Inc.

Keep Reading →